Hydromorphone neuroexcitation

Journal of Palliative Medicine

Volumn 7, Issue 4, 2004, Pages 545-550

  Thwaites, Daniel ^a,c   McCann, Shawn ^b   Broderick, Peter ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Diego Hospice & Palliative Care Center for Palliative Studies   (United States)

^c Community Hospice Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; HYDROMORPHONE; HYDROMORPHONE 3 GLUCURONIDE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AGITATION; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONTINUOUS INFUSION; EXCITABILITY; FEMALE; GENDER; HOSPICE; HUMAN; MALE; MAXIMUM PERMISSIBLE DOSE; METASTASIS; MYOCLONUS; NEUROEXCITATION; NEUROPATHOLOGY; NEUROTOXICITY; PAIN; PALLIATIVE THERAPY; SEIZURE; TERMINAL CARE; TERMINAL DISEASE;

ADULT; AGED; AKATHISIA, DRUG-INDUCED; ANALGESICS, OPIOID; CALIFORNIA; FEMALE; HOSPICES; HUMANS; HYDROMORPHONE; INCIDENCE; INFUSIONS, PARENTERAL; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCLONUS; RETROSPECTIVE STUDIES; SEIZURES; STATISTICS, NONPARAMETRIC;

EID: 4544267438     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2004.7.545     Document Type: Article

References (21)

1. Sarhill N, Walsh D, Nelson KA: Hydromorphone: Pharmacology and clinical applications in cancer patients. Support Care Cancer 2001;9:82-96.
2. Miller MG, McCarthy N, O'Boyle CA, Kearney M: Continuous subcutaneous infusion of morphine vs. hydromorphone: a controlled trial. J Pain Symptom Manage 1999;18:9-16.
3. Quigley C, Wiffen P: A systemic review of hydromorphone in acute chronic pain. J Pain Symptom Manage 2003;25:169-178.
4. Al-Shahri MZ, Molina EH, Oneschuk D: Medication-focused approach to total pain: Poor symptom control, polypharmacy, and adverse reactions. Am J Hosp Palliat Care 2003;20:307-310.
5. Hagen N, Swanson R: Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: treatment strategies. J Pain Symptom Manage 1997;14:51-58.
6. Wilson RK, Weissman DE: Neuroexcitatory effects of opioids: Patient assessment, 2001. Fast Fact and Concepts #57. National Residency End-of-Life Curriculum Project.
7. Jemal A, Thorros A, Murray T, Thur M: Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
8. Ferris FD, Kerr IG, DeAngelis C, Sone M, Hume S: Inpatient Narcotic Infusions for Patients with Cancer Pain. J Palliat Care 1990;6:51-59.
9. Mercadante S: Pathophysiology and treatment of opioid-related myoclonus in cancer patients. Pain 1998;741:5-9.
10. Wright AWE, Mather LE, Smith MT: Hydromorphon-3-glucuronide a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide. Life Sci 2001;69:409-120.
11. Smith MT: Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 2000;27:524-528.
12. Babul N, Darke AC, Hagen N. Hydromorphone metabolite accumulation in renal failure [letter]. J Pain Symptom Manage 1995;10:184-186.
13. Mercdanta S: Opioid rotation for cancer pain: Rationale and clinical aspects. Cancer 1999;86:1856-1866.
14. Macdonald N, Der L, Allan S, Champion P: Opioid hyperexcitability: The application of alternate opioid therapy. Pain 1993;53:353-355.
15. de Stoutz MD, Bruera E, Suarez-Almazor M: Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995;10(5):378-384.
16. Fine PG: Ketamine: From anesthesia to palliative care. AAHPM Bull 2003;3:1, 6.
17. Bruera E, Franco JJ, Maltoni M, Watanabe S, Suarez-Almazor M: Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation. J Pain Symptom Manage 1995;10:287-291.
18. Kaiko RF: Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983;13:180-185.
19. Bruera E, Pereira J: Acute neuropsychiatric findings in a patient receiving fentanyl for cancer pain. Pain 1997;69:199-201.
20. Sarhill N, Davis MP, Walsh D, Nouneh D: Methadone-induced myoclonus in advanced cancer. Am J Hosp Palliat Care 2001;18:51-53.
21. Hagen N, Swanson R: Strychnine-like multifocal myoclonus and seizures in extremely high-dose opioid administration: Treatment strategies. J Pain Symptom Manage 1997;14:51-58.